About 1 result found for searched term "Luxeptinib" (0.439 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10850 | Luxeptinib | FLT3 |
| Luxeptinib (CG-806) is an orally active, reversible, first-in-class, non-covalent, potent pan-FLT3/pan-BTK inhibitor. Luxeptinib induces cell cycle blocking, apoptosis, or autophagy in acute myeloid leukemia. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
